Showing results (191-200 of 1,216) with videos related to
Sort By:
Pageof 122
Plos Biology|January 11, 2014
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studiesDavid Baker, Katie Lidster, Ana Sottomayor, et al.Multiple Sclerosis and Related Disorders|April 17, 2015
MSer - A new, neutral descriptor for someone with multiple sclerosisDavid Baker, George Pepper, Freddie Yauner, et al.Scientific Reports|July 2, 2025
Deep crustal magnetotelluric imaging of continental accretion and intracontinental deformation in central AustraliaGraham Heinson, Ben Kay, David Baker, et al.Multiple Sclerosis and Related Disorders|March 8, 2025
Clinical opinions and case studies on understanding and managing hypogammaglobulinaemia in multiple sclerosis: United Kingdom perspectiveSharmilee Gnanapavan, Angray Kang, David Baker, et al.Proteins|February 3, 2011
Role of conformational sampling in computing mutation-induced changes in protein structure and stabilityElizabeth H Kellogg, Andrew Leaver-Fay, David BakerChemical Communications (Cambridge, England)|October 21, 2010
Computational design of orthogonal nucleoside kinasesLingfeng Liu, Paul Murphy, David Baker, et al.Science (New York, N.Y.)|September 17, 2005
Toward high-resolution de novo structure prediction for small proteinsPhilip Bradley, Kira M S Misura, David BakerCNS & Neurological Disorders Drug Targets|May 16, 2012
Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factorsJohannes M van Noort, David Baker, Sandra AmorJoint Commission Journal on Quality and Patient Safety|November 1, 2005
Medication dosing errors for patients with renal insufficiency in ambulatory careClarence Yap, Daniel Dunham, Jason Thompson, et al.Protein Science : a Publication of the Protein Society|July 27, 2002
Contact order and ab initio protein structure predictionRichard Bonneau, Ingo Ruczinski, Jerry Tsai, et al.Pageof 122